Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-23T11:10:04.052Z Has data issue: false hasContentIssue false
  • English
  • Français

Current status of vaccination against African trypanosomiasis

Published online by Cambridge University Press:  05 May 2010

STEFAN MAGEZ ,
GUY CALJON ,
THAO TRAN ,
BENOÎT STIJLEMANS  and
MAGDALENA RADWANSKA
STEFAN MAGEZ*
Affiliation:
Unit of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Pleinlaan 2, B-1050Brussels, Belgium Department of Molecular and Cellular Interactions, VIB, Rijvisschestraat 120, B-9052Ghent, Belgium
GUY CALJON
Affiliation:
Unit of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Pleinlaan 2, B-1050Brussels, Belgium Department of Molecular and Cellular Interactions, VIB, Rijvisschestraat 120, B-9052Ghent, Belgium Unit of Entomology, Institute of Tropical Medicine Antwerp (ITM), Nationalestraat 155, B-2000Antwerp, Belgium
THAO TRAN
Affiliation:
Unit of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Pleinlaan 2, B-1050Brussels, Belgium Department of Molecular and Cellular Interactions, VIB, Rijvisschestraat 120, B-9052Ghent, Belgium
BENOÎT STIJLEMANS
Affiliation:
Unit of Cellular and Molecular Immunology, Vrije Universiteit Brussel (VUB), Pleinlaan 2, B-1050Brussels, Belgium Department of Molecular and Cellular Interactions, VIB, Rijvisschestraat 120, B-9052Ghent, Belgium
MAGDALENA RADWANSKA
Affiliation:
COST Office, Avenue Louise 149, B-1050Brussels, Belgium
*
*Corresponding author: E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Summary

Anti-trypanosomiasis vaccination still remains the best theoretical option in the fight against a disease that is continuously hovering between its wildlife reservoir and its reservoir in man and livestock. While antigentic variation of the parasite surface coat has been considered the major obstacle in the development of a functional vaccine, recent research into the biology of B cells has indicated that the problems might go further than that. This paper reviews past and current attempts to design both anti-trypanosome vaccines, as well as vaccines directed towards the inhibition of infection-associated pathology.

Keywords

TrypanosomiasisvaccinationB cells
Type
Research Article
Information
Parasitology , Volume 137 , Special Issue 14: African trypanosomiasis: New insights for disease control , December 2010 , pp. 2017 - 2027
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Askonas, B. A., Corsini, A. C., Clayton, C. E. and Ogilvie, B. M. (1979). Functional depletion of T- and B-memory cells and other lymphoid cell subpopulations-during trypanosomiasis. Immunology 36, 313–321.Google ScholarPubMed
Authié, E., Boulange, A., Muteti, D., Lalmanach, G., Gauthier, F. and Musoke, A. J. (2001). Immunisation of cattle with cysteine proteinases of Trypanosoma congolense: targetting the disease rather than the parasite. International Journal for Parasitology 31, 1429–1433.CrossRefGoogle ScholarPubMed
Authié, E., Duvallet, G., Robertson, C. and Williams, D. J. (1993). Antibody responses to a 33 kDa cysteine protease of Trypanosoma congolense: relationship to ‘trypanotolerance’ in cattle. Parasite Immunology 15, 465–474.CrossRefGoogle ScholarPubMed
Authié, E., Muteti, D. K., Mbawa, Z. R., Lonsdale-Eccles, J. D., Webster, P. and Wells, C. W. (1992). Identification of a 33-kilodalton immunodominant antigen of Trypanosoma congolense as a cysteine protease. Molecular and Biochemical Parasitology 56, 103–116.CrossRefGoogle ScholarPubMed
Balaban, N., Waithaka, H. K., Njogu, A. R. and Goldman, R. (1995). Intracellular antigens (microtubule-associated protein copurified with glycosomal enzymes) – possible vaccines against trypanosomiasis. Journal of Infectious Diseases 172, 845–850.CrossRefGoogle ScholarPubMed
Barry, J. D., Graham, S. V., Fotheringham, M., Graham, V. S., Kobryn, K. and Wymer, B. (1998). VSG gene control and infectivity strategy of metacyclic stage Trypanosoma brucei. Molecular and Biochemical Parasitology 91, 93–105.CrossRefGoogle ScholarPubMed
Barry, J. D., Hajduk, S. L., Vickerman, K. and Le Ray, D. (1979). Detection of multiple variable antigen types in metacyclic populations of Trypanosoma brucei. Transactions of the Royal Society of Tropical Medicine and Hygiene 73, 205–208.CrossRefGoogle ScholarPubMed
Berriman, M., Ghedin, E., Hertz-Fowler, C., Blandin, G., Renauld, H., Bartholomeu, D. C., Lennard, N. J., Caler, E., Hamlin, N. E., Haas, B., Böhme, U., Hannick, L., Aslett, M. A., Shallom, J., Marcello, L., Hou, L., Wickstead, B., Alsmark, U. C., Arrowsmith, C., Atkin, R. J., Barron, A. J., Bringaud, F., Brooks, K., Carrington, M., Cherevach, I., Chillingworth, T. J., Churcher, C., Clark, L. N., Corton, C. H., Cronin, A., Davies, R. M., Doggett, J., Djikeng, A., Feldblyum, T., Field, M. C., Fraser, A., Goodhead, I., Hance, Z., Harper, D., Harris, B. R., Hauser, H., Hostetler, J., Ivens, A., Jagels, K., Johnson, D., Johnson, J., Jones, K., Kerhornou, A. X., Koo, H., Larke, N., Landfear, S., Larkin, C., Leech, V., Line, A., Lord, A., Macleod, A., Mooney, P. J., Moule, S., Martin, D. M., Morgan, G. W., Mungall, K., Norbertczak, H., Ormond, D., Pai, G., Peacock, C. S., Peterson, J., Quail, M. A., Rabbinowitsch, E., Rajandream, M. A., Reitter, C., Salzberg, S. L., Sanders, M., Schobel, S., Sharp, S., Simmonds, M., Simpson, A. J., Tallon, L., Turner, C. M., Tait, A., Tivey, A. R., Van Aken, S., Walker, D., Wanless, D., Wang, S., White, B., White, O., Whitehead, S., Woodward, J., Wortman, J., Adams, M. D., Embley, T. M., Gull, K., Ullu, E., Barry, J. D., Fairlamb, A. H., Opperdoes, F., Barrell, B. G., Donelson, J. E., Hall, N., Fraser, C. M., Melville, S. E. and El-Sayed, N. M. (2005). The genome of the African trypanosome Trypanosoma brucei. Science 309, 416–422.CrossRefGoogle ScholarPubMed
Boutlis, C. S., Gowda, D. C., Naik, R. S., Maguire, G. P., Mgone, C. S., Bockarie, M. J., Lagog, M., Ibam, E., Lorry, K. and Anstey, N. M. (2002). Antibodies to Plasmodium falciparum glycosylphosphatidylinositols: inverse association with tolerance of parasitemia in Papua New Guinean children and adults. Infection and Immunity 70, 5052–5057.CrossRefGoogle ScholarPubMed
Caljon, G., Van Den Abbeele, J., Sternberg, J. M., Coosemans, M., De Baetselier, P. and Magez, S. (2006 a). Tsetse fly saliva biases the immune response to Th2 and induces anti-vector antibodies that are a useful tool for exposure assessment. International Journal for Parasitology 36, 1025–1035.CrossRefGoogle ScholarPubMed
Caljon, G., Van Den Abbeele, J., Stijlemans, B., Coosemans, M., De Baetselier, P. and Magez, S. (2006 b). Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response. Infection and Immunity 74, 6324–6330.CrossRefGoogle Scholar
Clayton, C. E., Ogilvie, B. M. and Askonas, B. A. (1979). Trypanosoma brucei infection in nude mice: B lymphocyte function is suppressed in the absence of T lymphocytes. Parasite Immunology 1, 39–48.CrossRefGoogle ScholarPubMed
Cornelissen, A. W., Bakkeren, G. A., Barry, J. D., Michels, P. A. and Borst, P. (1985). Characteristics of trypanosome variant antigen genes active in the tsetse fly. Nucleic Acids Research 13, 4661–4676.CrossRefGoogle ScholarPubMed
Crowe, J. S., Barry, J. D., Luckins, A. G., Ross, C. A. and Vickerman, K. (1983). All metacyclic variable antigen types of Trypanosoma congolense identified using monoclonal antibodies. Nature 306, 389–391.CrossRefGoogle ScholarPubMed
Crowe, J. S., Lamont, A. G., Barry, J. D. and Vickerman, K. (1984). Cytotoxicity of monoclonal antibodies to Trypanosoma brucei. Transactions of the Royal Society of Tropical Medicine and Hygiene 78, 508–513.CrossRefGoogle ScholarPubMed
de la Fuente, J., Rodríguez, M., Redondo, M., Montero, C., García-García, J. C., Méndez, L., Serrano, E., Valdés, M., Enriquez, A., Canales, M., Ramos, E., Boué, O., Machado, H., Lleonart, R., de Armas, C. A., Rey, S., Rodríguez, J. L., Artiles, M. and García, L. (1998). Field studies and cost-effectiveness analysis of vaccination with Gavac against the cattle tick Boophilus microplus. Vaccine 16, 366–373.CrossRefGoogle ScholarPubMed
Engstler, M., Pfohl, T., Herminghaus, S., Boshart, M., Wiegertjes, G., Heddergott, N. and Overath, P. (2007). Hydrodynamic flow-mediated protein sorting on the cell surface of trypanosomes. Cell 131, 505–515.CrossRefGoogle ScholarPubMed
Esser, K. M., Schoenbechler, M. J. and Gingrich, J. B. (1982). Trypanosoma rhodesiense blood forms express all antigen specificities relevant to protection against metacyclic (insect form) challenge. Journal of Immunology 129, 1715–1718.CrossRefGoogle ScholarPubMed
Gull, K. (2003). Host-parasite interactions and trypanosome morphogenesis: a flagellar pocketful of goodies. Current Opinions in Microbiology 6, 365–370.CrossRefGoogle ScholarPubMed
Haddow, J. D., Haines, L. R., Gooding, R. H., Olafson, R. W. and Pearson, T. W. (2005). Identification of midgut proteins that are differentially expressed in trypanosome-susceptible and normal tsetse flies (Glossina morsitans morsitans). Insect Biochemistry and Molecular Biology 35, 425–433.CrossRefGoogle ScholarPubMed
Hemphill, A., Lawson, D. and Seebeck, T. (1991). The cytoskeletal architecture of Trypanosoma brucei. Journal of Parasitology 77, 603–612.CrossRefGoogle ScholarPubMed
Holland, W. G., Do, T. T., Huong, N. T., Dung, N. T., Thanh, N. G., Vercruysse, J. and Goddeeris, B. M. (2003). The effect of Trypanosoma evansi infection on pig performance and vaccination against classical swine fever. Veterinary Parasitology 111, 115–123.CrossRefGoogle ScholarPubMed
Honigberg, B. M., Hampton, R. W. and Cunningham, I. (1991). Effect of polyclonal anti-procyclic antibodies on development of Trypanosoma brucei brucei in tsetse flies. Parasitology Research 77, 39–43.CrossRefGoogle ScholarPubMed
Jackson, D. G., Windle, H. J. and Voorheis, H. P. (1993). The identification, purification, and characterization of two invariant surface glycoproteins located beneath the surface coat barrier of bloodstream forms of Trypanosoma brucei. Journal of Biological Chemistry 268, 8085–8095.CrossRefGoogle ScholarPubMed
Kamanga-Sollo, E. I., Musoke, A. J., Nantulya, V. M., Rurangirwa, F. R. and Masake, R. A. (1991). Differences between N'Dama and Boran cattle in the ability of their peripheral blood leucocytes to bind antibody-coated trypanosomes. Acta Tropica 49, 109–117.CrossRefGoogle ScholarPubMed
Kamhawi, S., Belkaid, Y., Modi, G., Rowton, E. and Sacks, D. (2000). Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science 290, 1351–1354.CrossRefGoogle ScholarPubMed
Kennedy, P. (2009). Cytokines in central nervous system trypanosomiasis: cause, effect or both? Trends in Parasitology 103, 213–214.Google ScholarPubMed
Kinyua, J. K., Nguu, E. K., Mulaa, F. and Ndung'u, J. M. (2005). Immunization of rabbits with Glossina pallidipes tsetse fly midgut proteins: effects on the fly and trypanosome transmission. Vaccine 23, 3824–3828.CrossRefGoogle ScholarPubMed
Kohl, L. and Gull, K. (1998). Molecular architecture of the trypanosome cytoskeleton. Molecular and Biochemical Parasitology 93, 1–9.CrossRefGoogle ScholarPubMed
Lalmanach, G., Boulangé, A., Serveau, C., Lecaille, F., Scharfstein, J., Gauthier, F. and Authié, E. (2002). Congopain from Trypanosoma congolense: drug target and vaccine candidate. Biological Chemistry 383, 739–749.CrossRefGoogle ScholarPubMed
Le Ray, D., Barry, J. D. and Vickerman, K. (1978). Antigenic heterogeneity of metacyclic forms of Trypanosoma brucei. Nature 273, 300–302.CrossRefGoogle ScholarPubMed
Li, S. Q., Fung, M. C., Reid, S. A., Inoue, N. and Lun, Z. R. (2007). Immunization with recombinant beta-tubulin from Trypanosoma evansi induced protection against T. evansi, T. equiperdum and T. b. brucei infection in mice. Parasite Immunology 29, 191–199.CrossRefGoogle Scholar
Li, S. Q., Yang, W. B., Ma, L. J., Xi, S. M., Chen, Q. L., Song, X. W., Kang, J. and Yang, L. Z. (2009). Immunization with recombinant actin from Trypanosoma evansi induces protective immunity against T. evansi, T. equiperdum and T. b. brucei infection. Parasitology Research 104, 429–435.CrossRefGoogle ScholarPubMed
Lubega, G. W., Byarugaba, D. K. and Prichard, R. K. (2002 a). Immunization with a tubulin-rich preparation from Trypanosoma brucei confers broad protection against African trypanosomosis. Experimental Parasitology 102, 9–22.CrossRefGoogle ScholarPubMed
Lubega, G. W., Ochola, D. O. and Prichard, R. K. (2002 b). Trypanosoma brucei: anti-tubulin antibodies specifically inhibit trypanosome growth in culture. Experimental Parasitology 102, 134–142.CrossRefGoogle ScholarPubMed
MacAskill, J. A., Holmes, P. H., Whitelaw, D. D., Jennings, F. W. and Urquhart, G. M. (1983). Immune mechanisms in C57B1 mice genetically resistant to Trypanosoma congolense infection. II. Aspects of the humoral response. Parasite Immunology 5, 577–586.CrossRefGoogle ScholarPubMed
Magez, S., Radwanska, M., Drennan, M., Fick, L., Baral, T. N., Allie, N., Jacobs, M., Nedospasov, S., Brombacher, F., Ryffel, B. and De Baetselier, P. (2007). Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal transduction and macrophage-derived soluble TNF are crucial for nitric oxide-mediated Trypanosoma congolense parasite killing. Journal of Infectious Diseases 196, 954–962.CrossRefGoogle ScholarPubMed
Magez, S., Radwanska, M., Drennan, M., Fick, L., Baral, T. N., Brombacher, F. and De Baetselier, P. (2006). Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during Trypanosoma congolense Tc13 Infections. Journal of Infectious Disease 193, 1575–1583.CrossRefGoogle ScholarPubMed
Magez, S., Radwanska, M., Beschin, A., Sekikawa, K. and De Baetselier, P. (1999). Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infection and Immunity 67, 3128–3132.CrossRefGoogle ScholarPubMed
Magez, S., Stijlemans, B., Baral, T. and De Baetselier, P. (2002). VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology. Microbes and Infection 4, 999–1006.CrossRefGoogle ScholarPubMed
Magez, S., Stijlemans, B., Radwanska, M., Pays, E., Ferguson, M. A. and De Baetselier, P. (1998). The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. Journal of Immunology 160, 1949–1956.CrossRefGoogle ScholarPubMed
Magez, S., Truyens, C., Merimi, M., Radwanska, M., Stijlemans, B., Brouckaert, P., Brombacher, F., Pays, E. and De Baetselier, P. (2004). P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis. Journal of Infection Diseases 189, 527–539.CrossRefGoogle ScholarPubMed
Marcello, L. and Barry, J. D. (2007). From silent genes to noisy populations-dialogue between the genotype and phenotypes of antigenic variation. Journal of Eukaryote Microbiology 54, 14–17.CrossRefGoogle ScholarPubMed
Maudlin, I., Turner, M. J., Dukes, P. and Miller, N. (1984). Maintenance of Glossina morsitans morsitans on antiserum to procyclic trypanosomes reduces infection rates with homologous and heterologous Trypanosoma congolense stocks. Acta Tropica 41, 253–257.Google ScholarPubMed
Mbawa, Z. R., Gumm, I. D., Shaw, E. and Lonsdale-Eccles, J. D. (1992). Characterisation of a cysteine protease from bloodstream forms of Trypanosoma congolense. European Journal of Biochemistry 204, 371–379.CrossRefGoogle ScholarPubMed
McCulloch, R. and Horn, D. (2009). What has DNA sequencing revealed about the VSG expression sites of African trypanosomes? Trends in Parasitology 25, 359–363.CrossRefGoogle ScholarPubMed
Mitchell, L. A. and Pearson, T. W. (1983). Antibody responses induced by immunization of inbred mice susceptible and resistant to African trypanosomes. Infection and Immunity 40, 894–902.CrossRefGoogle ScholarPubMed
Mkunza, F., Olaho, W. M. and Powell, C. N. (1995). Partial protection against natural trypanosomiasis after vaccination with a flagellar pocket antigen from Trypanosoma brucei rhodesiense. Vaccine 13, 151–154.CrossRefGoogle ScholarPubMed
Murray, M., Hirumi, H. and Moloo, S. K. (1985). Suppression of Trypanosoma congolense, T. vivax and T. brucei infection rates in tsetse flies maintained on goats immunized with uncoated forms of trypanosomes grown in vitro. Parasitology 91, 53–66.CrossRefGoogle Scholar
Murray, P. K., Jennings, F. W., Murray, M. and Urqhart, G. M. (1974 a). The nature of immunosuppression in Trypanosoma brucei infections in mice. I. The role of the macrophage. Immunology 27, 815–824.Google ScholarPubMed
Murray, P. K., Jennings, F. W., Murray, M. and Urqhart, G. M. (1974 b). The nature of immunosuppression in Trypanosoma brucei infections in mice. II. The role of the T and B lymphocytes. Immunology 27, 825–840.Google ScholarPubMed
Mwangi, D. M., Munyua, W. K. and Nyaga, P. N. (1990). Immunosuppression in caprine trypanosomiasis: effects of acute Trypanosoma congolense infection on antibody response to anthrax spore vaccine. Tropical Animal Health and Production 22, 95–100.CrossRefGoogle ScholarPubMed
Naessens, J. (2006). Bovine trypanotolerance: A natural ability to prevent severe anaemia and haemophagocytic syndrome? International Journal for Parasitology 36, 521–528.CrossRefGoogle ScholarPubMed
Naik, R. S., Branch, O. H., Woods, A. S., Vijaykumar, M., Perkins, D. J., Nahlen, B. L., Lal, A. A., Cotter, R. J., Costello, C. E., Ockenhouse, C. F., Davidson, E. A. and Gowda, D. C. (2000). Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. Journal of Experimental Medicine 192, 1563–1576.CrossRefGoogle ScholarPubMed
Nantulya, V. M., Doyle, J. J. and Jenni, L. (1980 a). Studies on Trypanosoma (nannomonas) congolense III. Antigenic variation in three cyclically transmitted stocks. Parasitology 80, 123–131.CrossRefGoogle ScholarPubMed
Nantulya, V. M., Doyle, J. J. and Jenni, L. (1980 b). Studies on Trypanosoma (nannomonas) congolense IV. Experimental immunization of mice against tsetse fly challenge. Parasitology 80, 133–137.CrossRefGoogle ScholarPubMed
Nogge, G. and Giannetti, M. (1979). Midgut absorption of undigested albumin and other proteins by tsetse, Glossina M. morsitans (Diptera: Glossinidae). Journal of Medical Entomology 16, 263.CrossRefGoogle ScholarPubMed
Nogge, G. and Giannetti, M. (1980). Specific antibodies: a potential insecticide. Science 209, 1028–1029.CrossRefGoogle ScholarPubMed
Nolan, D. P., Geuskens, M. and Pays, E. (1999). N-linked glycans containing linear poly-N-acetyllactosamine as sorting signals in endocytosis in Trypanosoma brucei. Current Biology 9, 1169–1172.CrossRefGoogle ScholarPubMed
Nolan, D. P., Jackson, D. G., Windle, H. J., Pays, A., Geuskens, M., Michel, A., Voorheis, H. P. and Pays, E. (1997). Characterization of a novel, stage-specific, invariant surface protein in Trypanosoma brucei containing an internal, serine-rich, repetitive motif. Journal of Biological Chemistry 272, 29212–29221.CrossRefGoogle ScholarPubMed
O'Beirne, C., Lowry, C. M. and Voorheis, H. P. (1998). Both IgM and IgG anti-VSG antibodies initiate a cycle of aggregation-disaggregation of bloodstream forms of Trypanosoma brucei without damage to the parasite. Molecular and Biochemical Parasitology 91, 165–193.CrossRefGoogle ScholarPubMed
O'Gorman, G. M., Park, S. D., Hill, E. W., Meade, K. G., Coussens, P. M., Agaba, M., Naessens, J., Kemp, S. J. and MacHugh, D. E. (2009). Transcriptional profiling of cattle infected with Trypanosoma congolense highlights gene expression signatures underlying trypanotolerance and trypanosusceptibility. BMC Genomics 10, 207.CrossRefGoogle ScholarPubMed
Olenick, J. G., Wolff, R., Nauman, R. K. and McLaughlin, J. (1988). A flagellar pocket membrane fraction from Trypanosoma brucei rhodesiense: immunogold localization and nonvariant immunoprotection. Infection and Immunity 56, 92–98.CrossRefGoogle ScholarPubMed
Outchkourov, N. S., Roeffen, W., Kaan, A., Jansen, J., Luty, A., Schuiffel, D., van Gemert, G. J., van de Vegte-Bolmer, M., Sauerwein, R. W. and Stunnenberg, H. G. (2008). Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice. Proceedings of the National Academy of Sciences, USA 105, 4301–4305.CrossRefGoogle ScholarPubMed
Pan, W., Ogunremi, O., Wei, G., Shi, M. and Tabel, H. (2006). CR3 (CD11b/CD18) is the major macrophage receptor for IgM antibody-mediated phagocytosis of African trypanosomes: diverse effect on subsequent synthesis of tumor necrosis factor alpha and nitric oxide. Microbes and Infection 8, 1209–1218.CrossRefGoogle ScholarPubMed
Pinder, M., Libeau, G., Hirsch, W., Tamboura, I., Hauck-Bauer, R. and Roelants, G. E. (1984). Anti-trypanosome specific immune responses in bovids of differing susceptibility to African trypanosomiasis. Immunology 51, 247–258.Google ScholarPubMed
Radwanska, M., Guirnalda, P., De Trez, C., Ryffel, B., Black, S. and Magez, S. (2008). Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses. PLoS Pathogens 4, e1000078.CrossRefGoogle ScholarPubMed
Radwanska, M., Magez, S., Dumont, N., Pays, A., Nolan, D. and Pays, E. (2000 a). Antibodies raised against the flagellar pocket fraction of Trypanosoma brucei preferentially recognize HSP60 in cDNA expression library. Parasite Immunology 22, 639–650.CrossRefGoogle ScholarPubMed
Radwanska, M., Magez, S., Michel, A., Stijlemans, B., Geuskens, M. and Pays, E. (2000 b). Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei. Infection and Immunity 68, 848–860.CrossRefGoogle ScholarPubMed
Rasooly, R. and Balaban, N. (2004). Trypanosome microtubule-associated protein p15 as a vaccine for the prevention of African sleeping sickness. Vaccine 22, 1007–1015.CrossRefGoogle ScholarPubMed
Robinson, D. R. and Gull, K. (1991). Basal body movements as a mechanism for mitochondrial genome segregation in the trypanosome cell cycle. Nature 352, 731–733.CrossRefGoogle ScholarPubMed
Roditi, I. and Lehane, M. J. (2008). Interactions between trypanosomes and tsetse flies. Current Opinions in Microbiology 11, 345–351.CrossRefGoogle ScholarPubMed
Rurangirwa, F. R., Musoke, A. J., Nantulya, V. M. and Tabel, H. (1983). Immune depression in bovine trypanosomiasis: effects of acute and chronic Trypanosoma congolense and chronic Trypanosoma vivax infections on antibody response to Brucella abortus vaccine. Parasite Immunology 5, 267–276.CrossRefGoogle ScholarPubMed
Saraiva, E. M., de Figueiredo Barbosa, A., Santos, F. N., Borja-Cabrera, G. P., Nico, D., Souza, L. O., de Oliveira Mendes-Aguiar, C., de Souza, E. P., Fampa, P., Parra, L. E., Menz, I., Dias, J. G. Jr., de Oliveira, S. M. and Palatnik-de-Sousa, C. B. (2006). The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine. Vaccine 24, 2423–2431.CrossRefGoogle ScholarPubMed
Schofield, D. L., Hewitt, M. C., Evans, K., Siomos, M. A. and Seeberger, P. H. (2002). Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418, 785–789.CrossRefGoogle Scholar
Sharpe, R. T., Langley, A. M., Mowat, G. N., MacAskill, J. A. and Holmes, P. H. (1982). Immunosuppression in bovine trypanosomiasis: response of cattle infected with Trypanosoma congolense to foot-and-mouth disease vaccination and subsequent live virus challenge. Research in Veterinary Science 32, 289–293.CrossRefGoogle ScholarPubMed
Shi, M., Wei, G., Pan, W. and Tabel, H. (2005). Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense. Infection and Immunity 73, 8393–8396.CrossRefGoogle ScholarPubMed
Sileghem, M., Flynn, J. N., Logan-Henhrey, L. and Ellis, J. (1994). Tumour necrosis factor production by monocytes from cattle infected with Trypanosoma (Duttonella) vivax and Trypanosoma (Nannomonas) congolense: possible association with severity of anaemia associated with the disease. Parasite Immunology 16, 51–54.CrossRefGoogle ScholarPubMed
Steverding, D., Stierhof, Y. D., Chaudhri, M., Ligtenberg, M., Schell, D., Beck-Sickinger, A. G. and Overath, P. (1994). ESAG 6 and 7 products of Trypanosoma brucei form a transferrin binding protein complex. European Journal of Cell Biology 64, 78–87.Google Scholar
Stijlemans, B., Baral, T. N., Guilliams, M., Brys, L., Korf, J., Drennan, M., Van Den Abbeele, J., De Baetselier, P. and Magez, S. (2007). A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathology. Journal of Immunology 179, 4003–4014.CrossRefGoogle ScholarPubMed
Taylor, K. A. (1998). Immune responses of cattle to African trypanosomes: protective or pathogenic? International Journal for Parasitology 28, 219–240.CrossRefGoogle ScholarPubMed
Taylor, K. A., Lutje, V., Kennedy, D., Authié, E., Boulangé, A., Logan-Henfrey, L., Gichuki, B. and Gettinby, G. (1996). Trypanosoma congolense: B-lymphocyte responses differ between trypanotolerant and trypanosusceptible cattle. Experimental Parasitology 83, 106–116.CrossRefGoogle ScholarPubMed
Tetley, L., Vickerman, K. and Moloo, S. K. (1981). Absence of a surface coat from metacyclic Trypanosoma vivax: possible implications for vaccination against vivax trypanosomiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 75, 409–414.CrossRefGoogle ScholarPubMed
Thiakaki, M., Rohousova, I., Volfova, V., Volf, P., Chang, K. P. and Soteriadou, K. (2005). Sand fly specificity of saliva-mediated protective immunity in Leishmania amazonensis-BALB/c mouse model. Microbes and Infection 7, 760–766.CrossRefGoogle ScholarPubMed
Tran, T., Büscher, P., Vandenbuscche, G., Wyns, L., Messens, J. and De Greve, H. (2008). Heterologous expression, purification and characterisation of the extracellular domain of trypanosome invariant surface glycoprotein ISG75. Journal of Biotechnology 135, 247–254.CrossRefGoogle ScholarPubMed
Tran, T., Cleas, F., Dujardin, J. C. and Büscher, P. (2006). The invariant surface glycoprotein ISG75 gene family consists of two main groups in the Trypanozoon subgenus. Parasitology 133, 613–621.CrossRefGoogle ScholarPubMed
Urwyler, S., Studer, E., Renggli, C. K. and Roditi, I. (2007). A family of stage-specific alanine-rich proteins on the surface of epimastigote forms of Trypanosoma brucei. Molecular Microbiology 63, 218–228.CrossRefGoogle ScholarPubMed
Van Meirvenne, N., Janssens, P. G. and Magnus, E. (1975 a). Antigenic variation in syringe passaged populations of Trypanosoma (Trypanozoon) brucei. 1. Rationalization of the experimental approach. Annales de la Société Belge de Médecine Tropicale 55, 1–23.Google ScholarPubMed
Van Meirvenne, N., Janssens, P. G., Magnus, E., Lumsden, W. H. and Herbert, W. J. (1975 b). Antigenic variation in syringe passaged populations of Trypanosoma (Trypanozoon) brucei. II. Comparative studies on two antigenic-type collections. Annales de la Société Belge de Médecine Tropicale 55, 25–30.Google ScholarPubMed
Vickerman, K. (1978). Antigenic variation in trypanosomes. Nature 273, 613–617.CrossRefGoogle ScholarPubMed
Whitelaw, D. D., Scott, J. M., Reid, H. W., Holmes, P. H., Jennings, F. W. and Urquhart, G. M. (1979). Immunosuppression in bovine trypanosomiasis: studies with louping-ill vaccine. Research in Veterinary Science 26, 102–107.CrossRefGoogle ScholarPubMed
Willadsen, P., Bird, P., Cobon, G. S. and Hungerford, J. (1995). Commercialisation of a recombinant vaccine against Boophilus microplus. Parasitology 110 (Suppl), S43–S50.CrossRefGoogle ScholarPubMed
Willadsen, P., Riding, G. A., McKenna, R. V., Kemp, D. H., Tellam, R. L., Nielsen, J. N., Lahnstein, J., Cobon, G. S. and Gough, J. M. (1989). Immunologic control of a parasitic arthropod. Identification of a protective antigen from Boophilus microplus. Journal of Immunology 143, 1346–1351.CrossRefGoogle ScholarPubMed
Williams, D. J., Taylor, K., Newson, J., Gichuki, B. and Naessens, J. (1996). The role of anti-variable surface glycoprotein antibody responses in bovine trypanotolerance. Parasite Immunology 18, 209–218.CrossRefGoogle ScholarPubMed
Ziegelbauer, K., Multhaup, G. and Overath, P. (1992 b). Molecular characterization of two invariant surface glycoproteins specific for the bloodstream stage of Trypanosoma brucei. Journal of Biological Chemistry 267, 10797–10803.CrossRefGoogle ScholarPubMed
Ziegelbauer, K. and Overath, P. (1992 a). Identification of invariant surface glycoproteins in the bloodstream stage of Trypanosoma brucei. Journal of Biological Chemistry 267, 10791–10796.CrossRefGoogle ScholarPubMed
Ziegelbauer, K. and Overath, P. (1993). Organization of two invariant surface glycoproteins in the surface coat of Trypanosoma brucei. Infection and Immunity 61, 4540–4545.CrossRefGoogle ScholarPubMed